| Product Code: ETC6746543 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Live Attenuated Vaccines Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Live Attenuated Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 China Live Attenuated Vaccines Market - Industry Life Cycle |
3.4 China Live Attenuated Vaccines Market - Porter's Five Forces |
3.5 China Live Attenuated Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Live Attenuated Vaccines Market Revenues & Volume Share, By Development, 2021 & 2031F |
3.7 China Live Attenuated Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 China Live Attenuated Vaccines Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 China Live Attenuated Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 China Live Attenuated Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Live Attenuated Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of infectious diseases in China, leading to increased demand for live attenuated vaccines. |
4.2.2 Government initiatives and vaccination programs promoting the use of vaccines in China. |
4.2.3 Technological advancements in vaccine development and manufacturing processes. |
4.2.4 Rising awareness among the Chinese population regarding the importance of vaccination for disease prevention. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of live attenuated vaccines in China. |
4.3.2 Concerns regarding the safety and efficacy of live attenuated vaccines among some segments of the population. |
4.3.3 Challenges related to the storage and distribution of live attenuated vaccines, especially in remote areas with limited infrastructure. |
5 China Live Attenuated Vaccines Market Trends |
6 China Live Attenuated Vaccines Market, By Types |
6.1 China Live Attenuated Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Live Attenuated Vaccines Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Live Attenuated Vaccines Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.1.4 China Live Attenuated Vaccines Market Revenues & Volume, By Viral, 2021- 2031F |
6.2 China Live Attenuated Vaccines Market, By Development |
6.2.1 Overview and Analysis |
6.2.2 China Live Attenuated Vaccines Market Revenues & Volume, By Tissue Culture, 2021- 2031F |
6.2.3 China Live Attenuated Vaccines Market Revenues & Volume, By Embryonated Eggs, 2021- 2031F |
6.2.4 China Live Attenuated Vaccines Market Revenues & Volume, By Live Animals, 2021- 2031F |
6.3 China Live Attenuated Vaccines Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 China Live Attenuated Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.3.3 China Live Attenuated Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.3.4 China Live Attenuated Vaccines Market Revenues & Volume, By Rotavirus, 2021- 2031F |
6.3.5 China Live Attenuated Vaccines Market Revenues & Volume, By Yellow Fever, 2021- 2031F |
6.3.6 China Live Attenuated Vaccines Market Revenues & Volume, By Oral Polio, 2021- 2031F |
6.3.7 China Live Attenuated Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Live Attenuated Vaccines Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Live Attenuated Vaccines Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.3 China Live Attenuated Vaccines Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.4 China Live Attenuated Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Live Attenuated Vaccines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Live Attenuated Vaccines Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 China Live Attenuated Vaccines Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 China Live Attenuated Vaccines Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 China Live Attenuated Vaccines Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 China Live Attenuated Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Live Attenuated Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 China Live Attenuated Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 China Live Attenuated Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 China Live Attenuated Vaccines Market Import-Export Trade Statistics |
7.1 China Live Attenuated Vaccines Market Export to Major Countries |
7.2 China Live Attenuated Vaccines Market Imports from Major Countries |
8 China Live Attenuated Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates among target population groups in China. |
8.2 Research and development investments in new live attenuated vaccine formulations. |
8.3 Number of reported cases of vaccine-preventable diseases in China. |
8.4 Rate of adverse events following immunization (AEFIs) for live attenuated vaccines in China. |
8.5 Adoption rates of newly introduced live attenuated vaccines in the Chinese market. |
9 China Live Attenuated Vaccines Market - Opportunity Assessment |
9.1 China Live Attenuated Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Live Attenuated Vaccines Market Opportunity Assessment, By Development, 2021 & 2031F |
9.3 China Live Attenuated Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 China Live Attenuated Vaccines Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 China Live Attenuated Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 China Live Attenuated Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Live Attenuated Vaccines Market - Competitive Landscape |
10.1 China Live Attenuated Vaccines Market Revenue Share, By Companies, 2024 |
10.2 China Live Attenuated Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here